Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
17
Warrant Exposure
50
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 35%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.42 below $1 exchange minimum
📜 Warrant Exercise
model 25%
• Significant warrants: 17% of shares outstanding
Market Data
Market Cap$988.5K
Shares Outstanding3.29M
Float2.85M
Cash$6.94M
DebtN/A
Short InterestN/A
Institutional Holdings
7.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest7.9K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-03-31
xbrl
XBRL CONVERTIBLE
2018-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual ATXI Dilution Snapshot
Avenue Therapeutics, Inc. (ATXI) has a DilutionScore of 46/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 545,454.
- Recent SEC activity tracked for ATXI: xbrl on 2026-03-31; xbrl on 2018-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: